Regulatory Affairs
NAFDAC Warns Imo Patent Medicine Dealers Against Fake and Expired Drugs, Strengthens Pharmacovigilance Drive
NAFDAC has warned patent medicine dealers in Imo State against distributing unregistered, counterfeit and expired medicines following a sensitisation programme on pharmacovigilance and responsible medicines distribution across the state's three senatorial districts.
The National Agency for Food and Drug Administration and Control (NAFDAC) has warned patent medicine dealers in Imo State against the sale and distribution of unregistered, counterfeit, substandard and expired medicines, stressing that commercial interests must not take precedence over public health.
The warning was delivered by NAFDAC's Director-General, Professor Mojisola Adeyeye, during a sensitisation workshop on pharmacovigilance and medicines distribution safety organised for members of the Nigerian Association of Patent and Proprietary Medicine Dealers (NAPPMED) in Owerri on Friday, 6 November 2026.
Adeyeye, who was represented by the Agency's South-East Zonal Director, Festus Ukadike, cautioned medicine dealers against practices that compromise the safety and quality of medicines reaching consumers, particularly the sale of unregistered products and the illegal alteration of expiry dates.
She emphasised that unregistered medicinal products are considered fake and warned dealers against procuring medicines from questionable suppliers offering unusually attractive discounts.
The Director-General also reiterated that expired medicines must not be returned to circulation through the alteration or revalidation of their expiry dates.
NAFDAC Highlights Risks in Medicines Distribution
Addressing participants, NAFDAC officials raised concerns about unsafe practices within the medicines distribution chain, including falsification of product labels, illegal expiry-date alterations and the distribution of prohibited or discontinued medicinal products.
The Agency warned that operators involved in the falsification of medicines or illegal revalidation of expired products could face business closure, product forfeiture, administrative sanctions and criminal prosecution.
As part of its enforcement efforts, NAFDAC also highlighted the use of intelligence-driven surveillance and handheld digital scanners to strengthen supply-chain monitoring, identify illegal warehouses and detect non-compliant medicine vendors.
Dealers Urged to Strengthen Storage and Distribution Practices
Speaking on Good Storage and Distribution Practices, an Assistant Chief Regulatory Officer of NAFDAC, Cletus Agwu, emphasised the importance of maintaining medicine quality throughout the distribution chain.
He urged wholesalers and distributors to procure pharmaceutical products exclusively from authorised manufacturers and supply them only to legally permitted entities.
He also stressed the need for appropriate storage conditions, temperature control, quality management systems and accurate documentation to preserve the safety and integrity of medicines.
NAFDAC Promotes Adverse Drug Reaction Reporting
In a separate presentation on pharmacovigilance, the Imo State Coordinator of NAFDAC, Helen Okanya, explained the importance of monitoring the safety of medicines even after they have received regulatory approval and entered the market.
She encouraged patent medicine dealers to report suspected adverse drug reactions, product quality defects and suspected substandard medicines through recognised reporting channels, including NAFDAC's digital MedSafety App.
She explained that reporting medicine-related problems was an important public health responsibility intended to support the identification and resolution of safety concerns.
NAFDAC's pharmacovigilance system provides mechanisms for collecting and analysing medicine safety information to support regulatory decisions and promote the rational use of medicines.
NAPPMED Commits to Extending Sensitisation Across Imo State
In his response, the Imo State Chairman of NAPPMED, Cyprian Okonkwo, commended NAFDAC for the initiative, noting that the programme had improved members' understanding of regulatory compliance, safe medicine storage and their responsibilities towards consumers.
He pledged that the association would extend the knowledge gained from the sensitisation exercise to medicine vendors across all 27 local government areas of Imo State, particularly on identifying and rejecting banned, counterfeit and expired products.
The sensitisation programme covered the state's three senatorial districts: Owerri, Okigwe and Orlu, with the grand finale held in Owerri.
Implications for Medicines Safety
Patent medicine dealers occupy an important position in Nigeria's grassroots medicines distribution network. Their sourcing decisions, storage practices and adherence to regulatory requirements can influence the quality and safety of medicines available to communities.
Strengthening pharmacovigilance awareness among these operators is therefore important for improving the reporting of suspected adverse drug reactions and identifying medicine quality problems after products have entered circulation.
However, sensitisation must be complemented by sustained regulatory surveillance, appropriate enforcement and continued collaboration between NAFDAC and stakeholders across the medicines distribution chain.
The Imo State engagement highlights the need to make responsible medicines distribution, regulatory compliance and patient safety central to the operations of every medicine vendor.